Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Scientia Prof Kaarin Anstey
New Brain Health Guidelines – What GPs Can Do
Expert panel – Dr Georgia Rigas & Dr Nadia Tejani, facilitated by Dr Angela Kwong
Navigating Perimenopause and Menopause – Managing Weight, Health and Wellbeing in General Practice
A/Prof Daryl Efron
Autism & Mental Health Comorbidities
Dr Rebecca Purvis
Pharmacogenomics in General Practice
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
